Development of a Noninvasive Method for Detecting and Monitoring the Time Course of Helicobacter pylori Infection

Helicobacter pylori infection status following experimental inoculation of mice presently requires euthanasia. The purpose of this study was to develop a method for following the time course of H. pylori infection in live experimental animals. Twenty-six C57BL/6, Helicobacter-free female mice were inoculated with H. pylori Sydney strain 1, and 16 mice were sham inoculated. The mice were repeatedly tested during a period of about 1 year with an H. pylori species-specific primer-based PCR analysis of DNA extracted from fecal pellets of mice. The mice were euthanized at 6 months (n = 15) and 10 months (n = 15) to determine their infection status by histology, culture, and PCR of gastric specimens. H. pylori-inoculated mice were tested via the PCR method at 6 and 10 months prior to necropsy. Nine of 13 (69%) and 10 of 13 (77%) mice tested at 6 and 10 months, respectively, were positive. All sham-inoculated mice were negative. These two PCR results suggested a specificity of 100% with a sensitivity range between 69 and 77%. In contrast, sensitivity and specificity rose to 90 and 100% if groups of mice were tested once daily for 4 days. Seventy-seven to 85% of the experimental mice were also positive for H. pylori by culture. The histopathology demonstrated mild to severe gastritis. These findings demonstrate that the persistence or transience of H. pylori infection in live mice can be repeatedly evaluated over time. This method could allow the determination of the time course of infection and the efficacy of medications and/or vaccine without necropsy. Continue reading….

Founded in 2015, Shufflex Biomed is headquartered in Germantown, Maryland, about 30 miles from Washington, DC and also based in Lower Johnsonville in Monrovia, Liberia, West Africa.

Pathogens we target

Pathogens Con't

Technologies

Features

Dr. Dougbeh Chris Nyan, M.D.

Inventor, Multiplex Pathogen Diagnostic Test

  • Biomedical research scientist; specializes in infectious disease diagnostics
  • Medical Degree: Charité-Medical Faculty; Humboldt-University of Berlin, Germany
  • Scientist/Fellow: US National Institutes of Health (NIH)
  • Scientist/Fellow: Laboratory of Emerging Pathogens, FDA
  • Scientist: Naval Medical Research Center
  • Scientist: BioReliance, Inc.
  • Research Fellow: University of Pennsylvania School of Medicine
  • Senior Scientist: Nabi Biopharmaceuticals Corp.
  • Testified before the US Congress on September 17, 2014 on the Ebola outbreak
  • Director: Diaspora Ebola Task Force
  • Member: International Society for Infectious Diseases (ISID)
  • Member: The European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
  • Member: Data Safety Monitoring Board (DSMB), US-West African PREVAIL (Vaccine Trails)